Broadly neutralizing antibodies to SARS-CoV-2 and other human coronaviruses

Y Chen, X Zhao, H Zhou, H Zhu, S Jiang… - Nature reviews …, 2023 - nature.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a recently emerged
pathogenic human coronavirus that belongs to the sarbecovirus lineage of the genus …

A detailed overview of SARS-CoV-2 omicron: its sub-variants, mutations and pathophysiology, clinical characteristics, immunological landscape, immune escape, and …

S Chatterjee, M Bhattacharya, S Nag, K Dhama… - Viruses, 2023 - mdpi.com
The COVID-19 pandemic has created significant concern for everyone. Recent data from
many worldwide reports suggest that most infections are caused by the Omicron variant and …

Therapeutic strategies for COVID-19: progress and lessons learned

G Li, R Hilgenfeld, R Whitley, E De Clercq - Nature Reviews Drug …, 2023 - nature.com
Since the COVID-19 pandemic began, many potential therapeutics that target SARS-CoV-2
and/or human proteins to control viral infection have been investigated, with a few receiving …

The Delta and Omicron variants of SARS-CoV-2: what we know so far

VP Chavda, R Bezbaruah, K Deka, L Nongrang… - Vaccines, 2022 - mdpi.com
The world has not yet completely overcome the fear of the havoc brought by SARS-CoV-2.
The virus has undergone several mutations since its initial appearance in China in …

Twitter-based sentiment analysis and topic modeling of social media posts using natural language processing, to understand people's perspectives regarding COVID …

P Sv, JM Lorenz, R Ittamalla, K Dhama, C Chakraborty… - Vaccines, 2022 - mdpi.com
This study analyzed perceptions of Indians regarding COVID-19 booster dose vaccines
using natural language processing techniques, particularly, sentiment analysis and topic …

Development of variant‐proof severe acute respiratory syndrome coronavirus 2, pan‐sarbecovirus, and pan‐β‐coronavirus vaccines

J Zhou, Z Liu, G Zhang, W Xu, L Xing… - Journal of Medical …, 2023 - Wiley Online Library
The newly emerged severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2)
variants with high transmission rates and striking immune evasion have posed a serious …

Immune evasion of neutralizing antibodies by SARS-CoV-2 Omicron

L Wang, M Møhlenberg, P Wang, H Zhou - Cytokine & growth factor …, 2023 - Elsevier
Since its emergence at the end of 2019, severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) has caused the infection of more than 600 million people worldwide and has …

Pan‐coronavirus fusion inhibitors to combat COVID‐19 and other emerging coronavirus infectious diseases

Q Lan, L Wang, F Jiao, L Lu, S Xia… - Journal of Medical …, 2023 - Wiley Online Library
Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), the causative agent of the
currently ongoing coronavirus disease 2019 (COVID‐19) pandemic, has posed a serious …

The potential of nanobodies for COVID-19 diagnostics and therapeutics

DB Naidoo, AA Chuturgoon - Molecular Diagnosis & Therapy, 2023 - Springer
The infectious severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is the
causative agent for coronavirus disease 2019 (COVID-19). Globally, there have been …

SARS-CoV-2 viral variants can rapidly be identified for clinical decision making and population surveillance using a high-throughput digital droplet PCR assay

O Pernet, M Weisenhaus, C Stafylis, C Williams… - Scientific Reports, 2023 - nature.com
Epidemiologic surveillance of circulating SARS-CoV-2 variants is essential to assess impact
on clinical outcomes and vaccine efficacy. Whole genome sequencing (WGS), the gold …